Celanese Corporation Common Stock

CENYSECIK 1306830Basic Materials / Chemicalsfiscal year ends December74 quarters since 2008

Revenue, Q3 FY2026
$2.6B
+5.7% on Q3 FY2025
Net income
$74M
+105.5% on Q3 FY2025
Free cash flow
$469M
+22.5% on Q3 FY2025
Diluted EPS
$0.67
+105.4% on Q3 FY2025
Revenue, TTM
$9.8B
trailing four quarters
Net margin, TTM
2.7%
net income $262M
Free cash flow, TTM
$794M
$1.1B less $281M capex
Cash and equivalents
—
long-term debt $11.5B, Sep 30, 2026
Shares, 12-month change
+0.2%
110M shares, Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$14M
0.3% of market value
Market value
$5.6B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 3, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Celanese Corporation Common Stock reported revenue of $2.6B, +5.7% on Q3 FY2025, and net income of $74M (+105.5%). Operating margin was 7.7%. Free cash flow, operating cash flow less capital expenditures, was $469M ($538M less $69M). Diluted earnings per share were $0.67.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

CE daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $51.51 · H $51.60 · L $50.47 · C $51.41 · +0.29% on the dayOver the range: +28.62%, Nov 14, 2025 to Nov 13, 2026
$33$43$53$63$73Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 3, 2026.

Revenue and net incomeRevenueNet income
−$2B$0$2B$4BQ4'22, Revenue: $2.3BQ4'22, Net income: $767MQ4'22Q1'23, Revenue: $2.9BQ1'23, Net income: $91MQ1'23Q2'23, Revenue: $2.8BQ2'23, Net income: $220MQ2'23Q3'23, Revenue: $2.7BQ3'23, Net income: $951MQ3'23Q4'23, Revenue: $2.6BQ4'23, Net income: $698MQ4'23Q1'24, Revenue: $2.6BQ1'24, Net income: $121MQ1'24Q2'24, Revenue: $2.7BQ2'24, Net income: $155MQ2'24Q3'24, Revenue: $2.6BQ3'24, Net income: $113MQ3'24Q4'24, Revenue: $2.4BQ4'24, Net income: −$1.9BQ4'24Q1'25, Revenue: $2.4BQ1'25, Net income: −$24MQ1'25Q2'25, Revenue: $2.5BQ2'25, Net income: $197MQ2'25Q3'25, Revenue: $2.4BQ3'25, Net income: −$1.4BQ3'25Q4'25, Revenue: $2.2BQ4'25, Net income: $19MQ4'25Q1'26, Revenue: $2.3BQ1'26, Net income: $44MQ1'26Q2'26, Revenue: $2.8BQ2'26, Net income: $125MQ2'26Q3'26, Revenue: $2.6BQ3'26, Net income: $74MQ3'26−$2B$0$2B$4BQ4'22, Revenue: $2.3BQ4'22, Net income: $767MQ4'22Q1'23, Revenue: $2.9BQ1'23, Net income: $91MQ1'23Q2'23, Revenue: $2.8BQ2'23, Net income: $220MQ2'23Q3'23, Revenue: $2.7BQ3'23, Net income: $951MQ3'23Q4'23, Revenue: $2.6BQ4'23, Net income: $698MQ4'23Q1'24, Revenue: $2.6BQ1'24, Net income: $121MQ1'24Q2'24, Revenue: $2.7BQ2'24, Net income: $155MQ2'24Q3'24, Revenue: $2.6BQ3'24, Net income: $113MQ3'24Q4'24, Revenue: $2.4BQ4'24, Net income: −$1.9BQ4'24Q1'25, Revenue: $2.4BQ1'25, Net income: −$24MQ1'25Q2'25, Revenue: $2.5BQ2'25, Net income: $197MQ2'25Q3'25, Revenue: $2.4BQ3'25, Net income: −$1.4BQ3'25Q4'25, Revenue: $2.2BQ4'25, Net income: $19MQ4'25Q1'26, Revenue: $2.3BQ1'26, Net income: $44MQ1'26Q2'26, Revenue: $2.8BQ2'26, Net income: $125MQ2'26Q3'26, Revenue: $2.6BQ3'26, Net income: $74MQ3'26−$2B$0$2B$4BQ4'22, Revenue: $2.3BQ4'22, Net income: $767MQ1'23, Revenue: $2.9BQ1'23, Net income: $91MQ1'23Q2'23, Revenue: $2.8BQ2'23, Net income: $220MQ3'23, Revenue: $2.7BQ3'23, Net income: $951MQ3'23Q4'23, Revenue: $2.6BQ4'23, Net income: $698MQ1'24, Revenue: $2.6BQ1'24, Net income: $121MQ1'24Q2'24, Revenue: $2.7BQ2'24, Net income: $155MQ3'24, Revenue: $2.6BQ3'24, Net income: $113MQ3'24Q4'24, Revenue: $2.4BQ4'24, Net income: −$1.9BQ1'25, Revenue: $2.4BQ1'25, Net income: −$24MQ1'25Q2'25, Revenue: $2.5BQ2'25, Net income: $197MQ3'25, Revenue: $2.4BQ3'25, Net income: −$1.4BQ3'25Q4'25, Revenue: $2.2BQ4'25, Net income: $19MQ1'26, Revenue: $2.3BQ1'26, Net income: $44MQ1'26Q2'26, Revenue: $2.8BQ2'26, Net income: $125MQ3'26, Revenue: $2.6BQ3'26, Net income: $74MQ3'26

Net income losses drawn in red.

Free cash flow
−$500M−$250M$0$250M$500M$750MQ4'22, Free cash flow: $398MQ4'22Q1'23, Free cash flow: −$260MQ1'23Q2'23, Free cash flow: $617MQ2'23Q3'23, Free cash flow: $272MQ3'23Q4'23, Free cash flow: $702MQ4'23Q1'24, Free cash flow: −$36MQ1'24Q2'24, Free cash flow: $187MQ2'24Q3'24, Free cash flow: −$9MQ3'24Q4'24, Free cash flow: $389MQ4'24Q1'25, Free cash flow: −$65MQ1'25Q2'25, Free cash flow: $317MQ2'25Q3'25, Free cash flow: $383MQ3'25Q4'25, Free cash flow: $168MQ4'25Q1'26, Free cash flow: $10MQ1'26Q2'26, Free cash flow: $147MQ2'26Q3'26, Free cash flow: $469MQ3'26−$500M−$250M$0$250M$500M$750MQ4'22, Free cash flow: $398MQ4'22Q1'23, Free cash flow: −$260MQ1'23Q2'23, Free cash flow: $617MQ2'23Q3'23, Free cash flow: $272MQ3'23Q4'23, Free cash flow: $702MQ4'23Q1'24, Free cash flow: −$36MQ1'24Q2'24, Free cash flow: $187MQ2'24Q3'24, Free cash flow: −$9MQ3'24Q4'24, Free cash flow: $389MQ4'24Q1'25, Free cash flow: −$65MQ1'25Q2'25, Free cash flow: $317MQ2'25Q3'25, Free cash flow: $383MQ3'25Q4'25, Free cash flow: $168MQ4'25Q1'26, Free cash flow: $10MQ1'26Q2'26, Free cash flow: $147MQ2'26Q3'26, Free cash flow: $469MQ3'26−$500M−$250M$0$250M$500M$750MQ4'22, Free cash flow: $398MQ1'23, Free cash flow: −$260MQ1'23Q2'23, Free cash flow: $617MQ3'23, Free cash flow: $272MQ3'23Q4'23, Free cash flow: $702MQ1'24, Free cash flow: −$36MQ1'24Q2'24, Free cash flow: $187MQ3'24, Free cash flow: −$9MQ3'24Q4'24, Free cash flow: $389MQ1'25, Free cash flow: −$65MQ1'25Q2'25, Free cash flow: $317MQ3'25, Free cash flow: $383MQ3'25Q4'25, Free cash flow: $168MQ1'26, Free cash flow: $10MQ1'26Q2'26, Free cash flow: $147MQ3'26, Free cash flow: $469MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ4'22, Cash and equivalents: $1.5BQ4'22, Long-term debt: $14.0BQ4'22Q1'23, Long-term debt: $13.4BQ1'23Q2'23, Long-term debt: $12.9BQ2'23Q3'23, Long-term debt: $12.3BQ3'23Q4'23, Long-term debt: $13.4BQ4'23Q1'24, Long-term debt: $13.4BQ1'24Q2'24, Long-term debt: $13.0BQ2'24Q3'24, Long-term debt: $12.8BQ3'24Q4'24, Long-term debt: $12.5BQ4'24Q1'25, Long-term debt: $12.6BQ1'25Q2'25, Long-term debt: $12.9BQ2'25Q3'25, Long-term debt: $12.8BQ3'25Q4'25, Long-term debt: $12.6BQ4'25Q1'26, Long-term debt: $12.6BQ1'26Q2'26, Long-term debt: $12.0BQ2'26Q3'26, Long-term debt: $11.5BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $1.5BQ4'22, Long-term debt: $14.0BQ4'22Q1'23, Long-term debt: $13.4BQ1'23Q2'23, Long-term debt: $12.9BQ2'23Q3'23, Long-term debt: $12.3BQ3'23Q4'23, Long-term debt: $13.4BQ4'23Q1'24, Long-term debt: $13.4BQ1'24Q2'24, Long-term debt: $13.0BQ2'24Q3'24, Long-term debt: $12.8BQ3'24Q4'24, Long-term debt: $12.5BQ4'24Q1'25, Long-term debt: $12.6BQ1'25Q2'25, Long-term debt: $12.9BQ2'25Q3'25, Long-term debt: $12.8BQ3'25Q4'25, Long-term debt: $12.6BQ4'25Q1'26, Long-term debt: $12.6BQ1'26Q2'26, Long-term debt: $12.0BQ2'26Q3'26, Long-term debt: $11.5BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $1.5BQ4'22, Long-term debt: $14.0BQ1'23, Long-term debt: $13.4BQ1'23Q2'23, Long-term debt: $12.9BQ3'23, Long-term debt: $12.3BQ3'23Q4'23, Long-term debt: $13.4BQ1'24, Long-term debt: $13.4BQ1'24Q2'24, Long-term debt: $13.0BQ3'24, Long-term debt: $12.8BQ3'24Q4'24, Long-term debt: $12.5BQ1'25, Long-term debt: $12.6BQ1'25Q2'25, Long-term debt: $12.9BQ3'25, Long-term debt: $12.8BQ3'25Q4'25, Long-term debt: $12.6BQ1'26, Long-term debt: $12.6BQ1'26Q2'26, Long-term debt: $12.0BQ3'26, Long-term debt: $11.5BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.

Celanese Corporation Common Stock income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 3, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue2,5562,7522,3372,2042,4192,5322,3892,358+5.7%
Cost of revenue2,0172,1341,8691,7811,8981,9981,9151,832+6.3%
Gross profit539618468423521534474526+3.5%
Research and development2929283231313131−6.5%
Selling, general and administrative248251226223231214231263+7.4%
Operating income19827621493(1,275)231165(1,419)+115.5%
Other income (expense)6(17)104120+50.0%
Pretax income931428213(1,360)133(6)(1,533)+106.8%
Income tax141133(15)(7)(77)9384+300.0%
Net income741254419(1,357)197(24)(1,925)+105.5%
Diluted EPS ($)0.671.130.40—(12.39)1.80(0.22)—+105.4%
Diluted shares (millions)110110110—110110109——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.

Celanese Corporation Common Stock balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 3, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents—————————
Short-term investments—————————
Total current assets5,4905,7955,9695,6936,0905,6755,4185,126−9.9%
Total assets20,93421,40821,73521,69522,16923,71323,19722,838−5.6%
Total current liabilities4,3504,0064,3163,6833,7272,7672,7973,890+16.7%
Long-term debt11,54512,01312,59912,61412,76512,87612,55812,527−9.6%
Total debt11,54512,01312,59912,70412,76512,87612,55812,635−9.6%
Total liabilities—————————
Stockholders’ equity4,2164,1674,0634,0493,9545,2545,1375,129+6.6%
Shares outstanding (millions)110110110110110110109109—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.

Celanese Corporation Common Stock cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 3, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 24, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow5382097625244741037494+20.4%
Capital expenditures696266846493102105+7.8%
Free cash flow (CFO − capex)46914710168383317(65)389+22.5%
Depreciation and amortization210244201196194190180185+8.2%
Share repurchases—————————
Dividends paid433433377+33.3%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 24, 2026.

Income statement

Celanese Corporation Common Stock income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 24, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 23, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 10, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 6, 2020FY2018ended Dec 31, 2018filed Feb 7, 2019FY2017ended Dec 31, 2017filed Feb 9, 2018FY2016ended Dec 31, 2016filed Feb 10, 2017FY2015ended Dec 31, 2015filed Feb 5, 2016FY2014ended Dec 31, 2014filed Feb 6, 2015FY2013ended Dec 31, 2013filed Feb 7, 2014FY2012ended Dec 31, 2012filed Feb 8, 2013FY2011ended Dec 31, 2011filed Feb 10, 2012FY2010ended Dec 31, 2010filed Feb 11, 2011FY2009ended Dec 31, 2009filed Feb 12, 2010FY2008ended Dec 31, 2008filed Jul 29, 2009FY2007ended Dec 31, 2007filed Jul 29, 2009
Revenue9,54410,26810,9269,6738,5375,6556,2977,1556,1405,3895,6746,8026,5106,4186,7635,9185,0826,8236,444
Cost of revenue7,5927,9328,3437,2935,8554,3624,6915,1834,6293,9844,3565,1865,1455,2375,3464,7384,0795,5674,999
Gross profit1,9522,3362,5832,3802,6821,2931,6061,9721,5111,4051,3181,6161,3651,1811,4171,1801,0031,2561,445
Research and development12513014611286746772737811986851049870707573
Selling, general and administrative8991,0331,077824633482483546496378506758311830805505474545516
Operating income(786)(720)1,6651,3781,9466648341,3348579343267581,508175402503290440748
Other income (expense)740259(5)5(8)83(2)(8)(4)0514743(25)
Pretax income(1,220)(1,019)1,1611,4212,2482,2519881,5101,0751,0304889411,609321467538251——
Income tax(90)507(795)(489)330247124292213122201314508(55)41112(243)63110
Net income(1,165)(1,542)1,9431,8941,8901,9858521,2078439003046241,101372427377498281426
Diluted EPS ($)(10.64)(14.11)17.7617.3416.8616.756.848.916.096.182.004.006.912.332.692.383.171.722.49
Diluted shares (millions)110109109109112118125135138146152156159160159158157163171

Balance sheet

Celanese Corporation Common Stock balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 24, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 23, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 10, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 6, 2020FY2018ended Dec 31, 2018filed Feb 7, 2019FY2017ended Dec 31, 2017filed Feb 9, 2018FY2016ended Dec 31, 2016filed Feb 10, 2017FY2015ended Dec 31, 2015filed Feb 5, 2016FY2014ended Dec 31, 2014filed Feb 6, 2015FY2013ended Dec 31, 2013filed Feb 7, 2014FY2012ended Dec 31, 2012filed Feb 8, 2013FY2011ended Dec 31, 2011filed Feb 10, 2012FY2010ended Dec 31, 2010filed Feb 11, 2011FY2009ended Dec 31, 2009filed Feb 12, 2010FY2008ended Dec 31, 2008filed Jul 29, 2009FY2007ended Dec 31, 2007filed Jul 29, 2009
Cash and equivalents———1,5085369554634395766389677809849596827401,254676825
Short-term investments————105334031323030324153647836—
Total current assets5,6935,1266,2186,6113,8073,7632,7652,8742,7922,4722,7872,6983,1822,8392,7032,6682,8562,286—
Total assets21,69522,83826,59726,27211,97510,9099,4769,3139,5388,3578,5868,7969,0189,0008,5188,2818,4127,166—
Total current liabilities3,6833,8904,0724,0682,5051,9731,7541,7791,5591,0771,5501,3381,5451,3551,3851,5421,6071,369—
Long-term debt12,61412,52713,40013,9533,7223,6713,4552,9703,3152,8902,4682,5862,8872,9302,8732,9903,2593,300—
Total debt12,70412,63513,75814,7533,9863,7363,9233,5493,6613,0292,9992,7453,0643,0983,0173,0643,5013,533—
Total liabilities———————————————————
Stockholders’ equity4,0495,1297,0655,6374,1893,5262,5072,9842,8872,5882,3782,8182,6991,7301,341926586182—
Shares outstanding (millions)110109109108108114120128136141147153157160156156146——

Cash flow statement

Celanese Corporation Common Stock cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 24, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 23, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 10, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 6, 2020FY2018ended Dec 31, 2018filed Feb 7, 2019FY2017ended Dec 31, 2017filed Feb 9, 2018FY2016ended Dec 31, 2016filed Feb 10, 2017FY2015ended Dec 31, 2015filed Feb 5, 2016FY2014ended Dec 31, 2014filed Feb 6, 2015FY2013ended Dec 31, 2013filed Feb 7, 2014FY2012ended Dec 31, 2012filed Feb 8, 2013FY2011ended Dec 31, 2011filed Feb 10, 2012FY2010ended Dec 31, 2010filed Feb 11, 2011FY2009ended Dec 31, 2009filed Feb 12, 2010FY2008ended Dec 31, 2008filed Jul 29, 2009FY2007ended Dec 31, 2007filed Jul 29, 2009
Operating cash flow1,1469661,8991,8191,7571,3431,4541,558803893862962762722638452596586566
Capital expenditures343435568543467364370337267246232254277349349201176274288
Free cash flow (CFO − capex)8035311,3311,2761,2909791,0841,221536647630708485373289251420312278
Depreciation and amortization760801706462371350352343305290357292305308298300319360311
Share repurchases—00171,0006509968055005004202501644531480378403
Dividends paid1330730529730429330028024120117414483433428232425

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$593K
7 purchases by 4 insiders; officers and directors $593K
Sold, twelve months
$0
0 sales by 0 insiders; officers and directors $0

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 6, 2026Fernandez-Moreno Luis MDirectoraward2,435$0.00—2,435Nov 9, 2026
Aug 14, 2026Kyrish ChuckSVP & CFOopen-market buy1,400$45.53$64K28,214Aug 17, 2026
Aug 14, 2026Kyrish ChuckSVP & CFOopen-market buy100$45.51$5K28,314Aug 17, 2026
Aug 14, 2026Kyrish ChuckSVP & CFOopen-market buy800$45.51$36K29,114Aug 17, 2026
Aug 11, 2026Duffie Ashley BSVP & GCopen-market buy600$45.60$27K31,925Aug 13, 2026
Aug 11, 2026Murray Mark ChristopherSVP - Acetylsopen-market buy2,153$45.52$98K30,432Aug 12, 2026
Aug 10, 2026Galante Edward GDirectoraward1,930$0.00—27,983Aug 12, 2026
May 11, 2026Chinn Bruce E.Directoraward2,975$0.00—7,261May 13, 2026
May 11, 2026Noonan Anne PDirectoraward2,975$0.00—2,975May 13, 2026
May 11, 2026Koenig MichaelDirectoraward2,975$0.00—8,320May 13, 2026
May 11, 2026Moorthy GaneshDirectoraward2,975$0.00—8,990May 13, 2026
May 11, 2026Kissire Deborah J.Directoraward2,975$0.00—4,075May 13, 2026
May 11, 2026Rucker Kim K.W.Directoraward2,975$0.00—3,031May 13, 2026
May 11, 2026Hill KathrynDirectoraward2,975$0.00—19,783May 13, 2026
May 11, 2026Kuehn Christopher JDirectoraward2,975$0.00—2,975May 13, 2026
May 11, 2026Galante Edward GDirectoraward4,676$0.00—26,053May 13, 2026
May 9, 2026Koenig MichaelDirectortax withholding1,013$57.51$58K5,345May 13, 2026
May 9, 2026Kissire Deborah J.Directordisposition to issuer3,376——1,100May 13, 2026
May 9, 2026Rucker Kim K.W.Directordisposition to issuer3,376——56May 13, 2026
May 9, 2026Kuehn Christopher JDirectordisposition to issuer3,376——0May 13, 2026
Feb 27, 2026Richardson Scott ACEO & President, Directoraward50,623$0.00—123,419Mar 3, 2026
Feb 27, 2026Murray Mark ChristopherSVP - Acetylsaward10,431$0.00—28,279Mar 3, 2026
Feb 27, 2026McGilvray Aaron MChief Accounting Officeraward1,687$0.00—11,991Mar 3, 2026
Feb 27, 2026Kyrish ChuckSVP & CFOaward15,678$0.00—26,814Mar 3, 2026
Feb 27, 2026Elliott Todd LSVP, EMaward12,579$0.00—37,945Mar 3, 2026

Full insider history for Celanese Corporation Common Stock, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held CE in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded CE by quarter.

FundManagerQuarterValueSharesWeightMove
Renaissance TechnologiesPeter BrownQ3 2026$2M49,7000.00%new

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
CELANESE CORPORATION, CIK 1306830 on EDGAR
Extract generated
November 16, 2026
Withheld
none
Repaired
2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2011, operating income FY2012
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total debt: LongTermDebt, combined, noncurrent+DebtCurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/CE.json